Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 16/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.41 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.41 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.41 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.41 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.40 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31677220 | 0.94 | MEN1 (0.41) | GPR119MEN1KMT2APDK1PDK2 | |
| SCHEMBL31024371 | 0.93 | GPR119 (0.43) | GPR119MEN1KMT2APDK1PDK2 | |
| SCHEMBL27137466 | 0.93 | GPR119 (0.41) | GPR119MEN1KMT2APDK1PDK2 | |
| SCHEMBL27123897 | 0.93 | GPR119 (0.43) | GPR119MEN1KMT2APDK1PDK2 | |
| SCHEMBL31024364 | 0.92 | MEN1 (0.42) | GPR119MEN1KMT2APDK1PDK2 | |
| SCHEMBL27124609 | 0.92 | MEN1 (0.42) | GPR119MEN1KMT2APDK1PDK2 | |
| SCHEMBL23123648 | 0.91 | CNR1 (0.43) | GPR119MEN1KMT2APDK1PDK2 | |
| SCHEMBL31161308 | 0.91 | CNR1 (0.43) | GPR119MEN1KMT2APDK1PDK2 | |
| SCHEMBL31024352 | 0.90 | GPR119 (0.45) | GPR119MEN1KMT2APDK1PDK2 | |
| SCHEMBL26099471 | 0.90 | MEN1 (0.52) | GPR119MEN1KMT2APDK1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240261418-A1 | SOS1 DEGRADING AGENT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | LEADINGTAC PHARMACEUTICAL (SHAOXING) CO., LTD. (CN) | 2024-08-08 | — | — | US | disclosed |
| CN-115232114-A | SOS1 degradation agent and preparation method and application thereof | 上海领泰生物医药科技有限公司 | 2022-10-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240261418-A1 | SOS1 DEGRADING AGENT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SOS1, RAC1, RSU1 | GPR119 3494/4885MEN1 805/4885KMT2A 4200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.